Vimarsana
Biggest News Aggregation in the World

Page 13 - High Throughput News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from High Throughput. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In High Throughput Today - Breaking & Trending Today

Global Clinical Diagnostics Automation Strategic Market - Vimarsana News

Global Clinical Diagnostics Automation Strategic Market

Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Clinical Diagnostics Automation: Global Strategic Business Report" report has been added to ...

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting - Vimarsana News

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting

Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. (“MGI”), today launched new revolutionary products and prices at Advances in Genome Biology and Technology (AGBT) General Meeting.

In-vitro Toxicology Testing Market Worth $64.7 Billion by 2030: Grand View Research, Inc. - Vimarsana News

In-vitro Toxicology Testing Market Worth $64.7 Billion by 2030: Grand View Research, Inc.

SAN FRANCISCO, Jan. 17, 2023 /PRNewswire/ -- The global in-vitro toxicology testing market size is projected to reach USD 64.7 billion by 2030, at a CAGR of 11.10% over the forecast period,

Complete Genomics Launches Full Sequencing Platforms - Vimarsana News

Complete Genomics Launches Full Sequencing Platforms

SAN FRANCISCO, CALIFORNIA, January 9, 2023 - Complete Genomics Inc(https://completegenomics.mgiamericas.com/), a subsidiary of MGI Tech Co., Ltd.

Evosep receives strategic investment from Novo Holding A/S to accelerate its effort on clinical proteomics - Vimarsana News

Evosep receives strategic investment from Novo Holding A/S to accelerate its effort on clinical proteomics

Evosep today announced that Novo Holdings A/S has become a minority shareholder in Evosep Aps with a US$ 40m investment to further Evosep’s technology and application portfolio for clinical proteomics.